Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.50
Bid: 55.50
Ask: 57.50
Change: 0.00 (0.00%)
Spread: 2.00 (3.604%)
Open: 56.50
High: 56.50
Low: 56.50
Prev. Close: 56.50
BSC Live PriceLast checked at -
British Smaller Companies VCT 2 is an Investment Trust

To create a portfolio that blends a mix of businesses operating in established industries with those that offer opportunities in the application and development of innovation.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

20 Sep 2022 09:30

RNS Number : 9593Z
British Smaller Companies VCT2 Plc
20 September 2022
 

British Smaller Companies VCT2 plc

Unaudited Interim Results and Interim Management Report

for the six months ended 30 June 2022

 

British Smaller Companies VCT2 plc (the "Company") today announces its unaudited interim results for the six months ended 30 June 2022.

HIGHLIGHTS

· Total Return increased by 0.3p to 139.8p per share

· Two new investments and four follow-on investments totalling £5.7 million were completed during the period. Subsequent to the period end, four follow-on investments totalling £2.4 million completed, bringing the total invested this year to £8.1 million, following the £6.1 million invested in the full year to 31 December 2021

· Net Asset Value at 30 June 2022 of 60.3p per share (31 December 2021: 61.5p) following payment of a 1.5p dividend per share on 6 May 2022

· Fully subscribed offer raised net proceeds of £24.2 million

· The Board has declared a second interim dividend of 1.5p per share in respect of the year ending 31 December 2022, which will bring total dividends paid in the current financial year to 3.0p per share

CHAIRMAN'S STATEMENT

In recent updates, I have discussed how the Company has enjoyed a strong performance, driven by the accelerating transition of many areas of the economy to have a greater focus on technology-led solutions, as a result of the Covid-19 pandemic. However, since the start of the year sentiment towards technology stocks has cooled, as inflationary concerns have driven up interest rates in the western world.

When set against this backdrop, it is pleasing to report that the Company has continued to grow, recording a 0.3 pence total return in the period. This current resilience in a challenging environment arises from the portfolio's significant business-to-business focus, with clients continuing to adopt and use tools and services delivered by portfolio companies even as the economic environment is becoming more challenging.

This continuing performance has seen a number of the investments within the portfolio seeking to extend their growth plans, with the Company supportive of providing further long term funding to businesses with growth potential that can deliver value through economic cycles. This has resulted in further investment of £2.7 million into four portfolio companies in the period. At the same time, the Company has added two new investments, totalling £3.0 million. Subsequent to the period end, a further £2.4 million has also been invested into four portfolio companies, taking the total invested so far this year to £8.1 million, following the £6.1 million invested in the full year to 31 December 2021.

Financial Results

The portfolio generated a return of £2.4 million in the period, driven by positive revaluations from a number of companies, particularly those based in UK regions outside of London. The movement in net asset value ("NAV") per ordinary share and the dividends paid are set out in the table below. The allotment of shares from the 2021/22 fundraising reduces total return per share as the fundraising was priced at the 30 September 2021 NAV per share but allotted shortly after 31 December 2021 for operational purposes.

Pence per ordinary share

£000

NAV at 31 December 2021

61.5p

87,375

Net gain arising from investment portfolio

1.3p

2,364

Incentive fee accrual

(0.2p)

(363)

Net operating costs

(0.5p)

(838)

Issue/buy-back of new shares

(0.3p)

23,816

Total Return in period

0.3p

24,979

NAV before the payment of dividends

 

61.8p

 

112,354

Dividends paid

(1.5p)

(2,718)

NAV at 30 June 2022

 

60.3p

 

109,636

Cumulative dividends paid

79.5p

Total Return:

At 30 June 2022

 

139.8p

At 31 December 2021

 

139.5p

Investments made since the changes to the VCT rules in November 2015 now comprise £58.4 million (75 per cent, cost of £35.0 million) of the unquoted portfolio as at 30 June 2022, with £19.8 million (25 per cent, cost of £12.8 million) of investments made prior to the rule changes. In general, the more recent additions to the portfolio are re-investing their profits for growth, with those investments comprising mainly equity instruments.

Dividends

An interim dividend of 1.5 pence per ordinary share in respect of the year ending 31 December 2022 was paid on 6 May 2022, bringing the cumulative dividends paid to date to 79.5 pence per ordinary share. 

Your Board has proposed a second interim dividend of 1.5 pence per ordinary share for the year ending 31 December 2022 which, when combined with the above dividend paid in May, will bring total dividends paid in the current financial year to 3.0 pence per ordinary share (2021: 8.0 pence per ordinary share). The interim dividend will be paid on 3 October 2022 to shareholders on the register on 2 September 2022. 

Shareholder Relations

The shareholder workshop, held on 29 June 2022 was well attended. Attendees heard from economist and author Paul Collier and Ben Hookway, CEO of Relative Insight, one of the Company's recent investments. As Matthew Scullion of Matillion was unable to attend in person, there was a short film of him being interviewed and the YFM team provided an update on the financial performance and the portfolio, along with a glimpse into the future. The Matillion interview and the slides can be viewed on the website www.bscfunds.com.

Following the popularity of the online webinars over the past couple of years, we will be hosting a further event in December 2022.

Documents such as the annual report are now received by 82 per cent of shareholders electronically, rather than by post, which helps to meet the Board's impact objectives and reduces printing costs. Your Board continues to encourage all shareholders to take up this option.

Your Company's website is refreshed on a regular basis and provides a comprehensive level of information in what I hope is a user-friendly format.

Registrars

The Company is in the process of changing its registrar, from Link Group to The City Partnership; transition is expected to take place over the weekend of 21-23 October 2022; The City Partnership will send further correspondence on this to all shareholders in due course.

Regulatory Developments

In the period there have been no regulatory changes that impact your Company; the Manager continues to monitor for any amendments.

Most new portfolio investments are now self-assured as VCT qualifying on a case-by-case basis and always with confirmation from professional advisers that they are Qualifying Investments. Advance assurance is sought where there is an element of uncertainty over the application of the rules.

Fundraising

The Company allotted 40,224,521 shares in January 2022, relating to the 2021/22 fundraising, after which net proceeds of £24.2 million were received.

On 2 August 2022, the Company announced its intention to launch a joint new offer for subscription for the tax year 2022/23 later this year, alongside British Smaller Companies VCT plc. A prospectus with full details of the proposed Offer will be published in due course.

Outlook

As noted above, the portfolio's resilience is encouraging in the face of an increasingly challenging economic environment. A planned fundraise later this year will maintain the Company's strong position to continue to support the portfolio, particularly with a growing focus on ensuring that companies are well funded through to profitability, and also allow the Company to take advantage of new opportunities arising across the UK.

I thank shareholders for their continued support.

Peter Waller

Chairman

OBJECTIVES AND STRATEGY

The Company's objective is to maximise Total Return and provide investors with a long-term tax free dividend yield whilst maintaining the Company's status as a venture capital trust.

The investment strategy of the Company is to invest in UK businesses across a broad range of sectors that blends a mix of businesses operating in established and emerging industries that offer opportunities in the application and development of innovation in their products and services.

These investments will all meet the definition of a Qualifying Investment and be primarily in unquoted UK companies. It is anticipated that the majority of these businesses will be re-investing their profits for growth and the investments will comprise mainly equity investments.

The Company seeks to build a diversified portfolio which ensures compliance with the VCT guidelines in this regard.

INVESTMENTREVIEW

The Company's portfolio at 30 June 2022 had a value of £78.2 million. Investments made since the VCT rule changes in 2015 comprised £58.4 million (75 per cent of the total value of the portfolio). The largest single investment represents 20.1 per cent of the net asset value.

The Company's portfolio delivered a positive performance over the period, generating a return of £2.4 million.

There were upward revaluations from Displayplan, Outpost, Springboard, Unbiased, Intelligent Office and ACC, offset by more difficult trading conditions at Arcus Global and Sipsynergy. Matillion's valuation reduced due to decreases in valuation multiples of comparable public companies

Realisation of Investments

There were no realisations during the period.

Investments

During the six months ended 30 June 2022, the Company completed six investments, totalling £5.7 million. This comprised two new investments of £3.0 million and four follow-on investments totalling £2.7 million. The breakdown of these investments is shown below:

Company

Investments made £million

 

New

Follow-on

Total

Relative Insight

2.0

-

2.0

Quality Clouds

1.0

-

1.0

Outpost

-

2.0

2.0

Sipsynergy

-

0.4

0.4

Other follow-on investments

-

0.3

0.3

Invested in the period

3.0

2.7

5.7

Relative Insight is an AI-based text analytics platform. The Company's investment will provide growth capital to expand operations in the US and strengthen new product development. Quality Clouds, a tool for the control and governance of critical SaaS platforms within corporations, will be supported to recruit and grow their sales teams in the UK and US. The follow-on investment into Outpost will help the company develop new studios in London and Mumbai, building their technology; while Sipsynergy's product is looking to exploit the widescale adoption of Microsoft Teams.

Subsequent to the period end the Company has invested £2.4 million into four portfolio companies.

Cash Deposits

Under the revised VCT legislation it is no longer possible to deposit funds for longer than seven days, which has reduced the Company's interest income from cash deposits. The Board and the Manager continually review opportunities to generate a higher level of income, without significantly changing the risk profile of the funds held. As part of this, the Company has recently invested into a small, diversified portfolio of listed investment funds. At 30 June 2022 this quoted portfolio was valued at £0.6 million, or 0.6 per cent of net assets.

 

INVESTMENT PORTFOLIO

The top 10 investments had a combined value of £56.4 million, 72.1 per cent of the total portfolio.

Name of Company

Sector

First

investment

Current

cost

 

Value at

30 June

2022

Proceeds

to date

 

 

Capital return to date

 

£000

£000

£000

£000

Matillion Limited

Data & Analytics

Nov 16

1,456

22,040

5,946

27,986

Springboard Research Holdings Limited

Data & Analytics

Oct 14

1,881

5,488

120

5,608

Outpost VFX Limited

New Media

Feb 21

3,000

5,325

-

5,325

Unbiased EC1 Limited

Software

Dec 19

1,964

4,229

-

4,229

Intelligent Office UK (IO Outsourcing Limited t/a as Intelligent Office

Business Services

May 14

1,956

3,843

-

3,843

DisplayPlan Holdings Limited

New Media

Jan 12

70

3,797

820

4,617

Wooshii Limited

New Media

May 19

2,440

3,248

-

3,248

Elucidat Ltd

Software

May 19

1,800

3,000

-

3,000

ACC Aviation Group Limited*

Business Services

Nov 14

145

2,752

1,233

3,985

SharpCloud Software Limited

Data & Analytics

Oct 19

2,271

2,657

-

2,657

Total top 10 investments

 

 

16,983

56,379

8,119

64,498

Remaining portfolio

Force24 Ltd

Software

Nov 20

1,600

2,649

-

2,649

Relative Insight Limited

Data & Analytics

Mar 22

2,000

2,107

-

2,107

KeTech Enterprises Limited

Data & Analytics

Nov 15

10

1,847

1,775

3,622

Vuealta Group Limited

Software

Sep 21

1,578

1,704

-

1,704

Tonkotsu Limited

Retail & Brands

Jun 19

1,592

1,535

-

1,535

Ncam Technologies Limited

New Media

Mar 18

1,675

1,506

87

1,593

Sipsynergy

(via Hosted Network Services Limited)

Software

Jun 16

2,045

1,505

-

1,505

Vypr Validation Technologies Limited

Data & Analytics

Jan 21

1,000

1,360

-

1,360

Frescobol Carioca Ltd

Retail & Brands

Mar 19

1,200

1,209

-

1,209

Quality Clouds Limited

Software

May 22

1,000

1,000

-

1,000

Traveltek Group Holdings Limited

Software

Oct 16

1,163

997

-

997

Panintelligence

(via Paninsight Limited)

Data & Analytics

Nov 19

1,000

921

-

921

e2E Engineering Limited

Business Services

Sep 17

600

729

-

729

£0.5 million and below

Other investments

14,338

2,713

5,384

8,097

Total investments

 

 

47,784

78,161

15,365

93,526

Full disposals to date

38,885

-

56,000

56,000

Total portfolio 

 

 

86,669

78,161

71,365

149,526

* Additional ordinary dividends of £1.93 million have also been received.

OUR PORTFOLIO AT A GLANCE

The charts on pages 12 and 13 of the interim report illustrate the broad range of the investment portfolio.

PRINCIPAL RISKS AND UNCERTAINTIES

In accordance with DTR 4.2.7, the Board confirms that the principal risks and uncertainties facing the Company have not materially changed from those identified in the Annual Report and Accounts for the year ended 31 December 2021. The Board acknowledges that there is regulatory risk and continues to manage the Company's affairs in such a manner as to comply with section 274 of the Income Tax Act 2007.

In summary, the principal risks are:

Loss of approval as a Venture Capital Trust;

• Economic;

• Investment and strategic;

• Regulatory;

• Reputational;

• Operational;

• Cyber/IT;

• Climate;

• Financial; and

• Market/liquidity.

Full details of the principal risks can be found in the financial statements for the year ended 31 December 2021 on pages 32 to 34, a copy of which is available at www.bscfunds.com.

DIRECTORS' RESPONSIBILITIES STATEMENT

The directors of British Smaller Companies VCT2 plc confirm that, to the best of their knowledge, the condensed set of financial statements in this interim report have been prepared in accordance with International Accounting Standard 34 "Interim Financial Reporting" as adopted by the UK, and give a true and fair view of the assets, liabilities, financial position and profit and loss of British Smaller Companies VCT2 plc, and that the interim management report includes a true and fair review of the information required by DTR 4.2.7R and DTR 4.2.8R.

The directors of British Smaller Companies VCT2 plc are listed in note 10.

By order of the Board

Peter Waller

Chairman

UNAUDITED STATEMENT OF COMPREHENSIVE INCOME

for the six months ended 30 June 2022

 

Unaudited 6 months ended

30 June 2022

Unaudited 6 months ended

30 June 2021

Notes

Revenue

Capital

Total

Revenue

Capital

Total

£000

£000

£000

£000

£000

£000

 

 

 

Gains on investments held at fair value

6

-

2,364

2,364

-

17,741

17,741

Gains on disposal of investments

-

-

-

-

105

105

-

2,364

2,364

-

17,846

17,846

Income

2

275

-

275

337

-

337

Total income

275

2,364

2,639

337

17,846

18,183

Administrative expenses:

 

 

 

Manager's fee

(205)

(613)

(818)

(163)

(491)

(654)

Incentive fee

7

-

(363)

(363)

-

(3,316)

(3,316)

Other expenses

(295)

-

(295)

(208)

-

(208)

(500)

(976)

(1,476)

(371)

(3,807)

(4,178)

(Loss) profit before taxation

(225)

1,388

1,163

(34)

14,039

14,005

Taxation

3

-

-

-

-

-

-

(Loss) profit for the period

(225)

1,388

1,163

(34)

14,039

14,005

Total comprehensive (expense) income for the period

(225)

1,388

1,163

(34)

14,039

14,005

Basic and diluted (loss) earnings per ordinary share

5

(0.13p)

0.77p

0.64p

(0.02p)

10.28p

10.26p

 

The Total column of this statement represents the Company's Unaudited Statement of Comprehensive Income, prepared in accordance with UK adopted international accounting standards. The supplementary Revenue and Capital columns are prepared under the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' (issued in April 2021 - "SORP") published by the Association of Investment Companies.

UNAUDITED BALANCE SHEET

as at 30 June 2022

 

Notes

Unaudited

30 June

2022

 

Unaudited

30 June

2021

 

Audited

31 December

2021

 

 

 

£000

£000

£000

ASSETS

 

 

 

 

Non-current assets at fair value through profit and loss

Investments

6

78,161

71,162

70,019

Listed investment funds

6

647

-

-

Financial assets at fair value through profit or loss

6

78,808

71,162

70,019

Accrued income and other assets

688

545

493

79,496

71,707

70,512

Current assets

 

 

 

Accrued income and other assets

48

131

217

Cash on fixed term deposit

1,988

1,988

1,988

Cash and cash equivalents

28,583

18,613

19,201

30,619

20,732

21,406

LIABILITIES

 

 

 

Current liabilities

 

 

Trade and other payables

(116)

(82)

(4,543)

Provisions for liabilities and charges

7

(363)

(3,316)

-

Net current assets

30,140

17,334

16,863

 

 

Net assets

109,636

89,041

87,375

 

 

Shareholders' equity

 

 

 

Share capital

19,921

15,483

15,808

Share premium account

430

22,634

24,122

Capital redemption reserve

88

88

88

Other reserve

2

2

2

Merger reserve

5,525

5,525

5,525

Capital reserve

52,519

15,498

12,818

Investment holding gains and losses reserve

30,373

27,154

28,009

Revenue reserve

778

2,657

1,003

Total shareholders' equity

 

109,636

89,041

87,375

Net asset value per ordinary share

8

60.3p

63.5p

61.5p

 

Signed on behalf of the Board

Peter Waller

Chairman

 

UNAUDITED STATEMENT OF CHANGES IN EQUITY

for the six months ended 30 June 2022

 

Share

capital

Share

premium

account

Other

reserves*

Capital

reserve

Investment

holding

gains and losses reserve

Revenue

reserve

Total

equity

 

£000

£000

£000

£000

£000

£000

£000

 

At 31 December 2020

14,133

16,735

5,615

22,461

9,254

2,731

70,929

 

Revenue loss for the period

-

-

-

-

-

(34)

(34)

 

Expenses charged to capital

-

-

-

(3,807)

-

-

(3,807)

 

Investment holding gain on investments held at fair value

-

-

-

-

17,741

-

17,741

 

Realisation of investments in the period

-

-

-

105

-

-

105

 

Total comprehensive (expense) income for the period

-

-

-

(3,702)

17,741

(34)

14,005

 

Issue of share capital

1,276

5,772

-

-

-

-

7,048

 

Issue of shares - DRIS

74

324

-

-

-

-

398

 

Issue costs

-

(197)

-

(47)

-

-

(244)

 

Purchase of own shares

-

-

-

(1,161)

-

-

(1,161)

 

Dividends

-

-

-

(1,934)

-

-

(1,934)

 

Total transactions with owners

1,350

5,899

-

(3,142)

-

-

4,107

 

Realisation of prior year investment holding losses

-

-

-

(119)

159

(40)

-

 

At 30 June 2021

15,483

22,634

5,615

15,498

27,154

2,657

89,041

 

Revenue loss for the period

-

-

-

-

-

(95)

(95)

 

Expenses charged to capital

-

-

-

(1,719)

-

-

(1,719)

 

Investment holding gain on investments held at fair value

-

-

-

-

2,961

-

2,961

 

Realisation of investments in the period

-

-

-

5,237

-

-

5,237

 

Total comprehensive income (expense) for the period

-

-

-

3,518

2,961

(95)

6,384

 

Issue of shares - DRIS

325

1,529

-

-

-

-

1,854

 

Issue costs

-

(41)

-

-

-

-

(41)

 

Purchase of own shares

-

-

-

(782)

-

-

(782)

 

Dividends

-

-

-

(7,522)

-

(1,559)

(9,081)

 

Total transactions with owners

325

1,488

-

(8,304)

-

(1,559)

(8,050)

 

Realisation of prior year investment holding losses

-

-

-

2,106

(2,106)

-

-

 

At 31 December 2021

15,808

24,122

5,615

12,818

28,009

1,003

87,375

 

Revenue loss for the period

-

-

-

-

-

(225)

(225)

Expenses charged to capital

-

-

-

(976)

-

-

(976)

Investment holding gain on investments held at fair value

-

-

-

-

2,364

-

2,364

Total comprehensive (expense) income for the period

-

-

-

(976)

2,364

(225)

1,163

Issue of share capital

4,023

21,274

-

-

-

-

25,297

Issue of shares - DRIS

90

452

-

-

-

-

542

Issue costs

-

(1,103)

-

-

-

-

(1,103)

Share premium cancellation

-

(44,315)

-

44,315

-

-

-

Purchase of own shares

-

-

-

(920)

-

-

(920)

Dividends

-

-

-

(2,718)

-

-

(2,718)

Total transactions with owners

4,113

(23,692)

-

40,677

-

-

21,098

At 30 June 2022

19,921

430

5,615

52,519

30,373

778

109,636

*Other reserves include the capital redemption reserve, the merger reserve and the other reserve, which are non-distributable.

Reserves available for distribution

Under the Companies Act 2006, the capital reserve and the revenue reserve are distributable reserves. The table below shows amounts that are available for distribution.

Capital reserve

Revenue reserve

Total

 

£000

£000

£000

Distributable reserves as above

52,519

778

53,297

Less: Income not yet distributable

(325)

(778)

(1,103)

Less: Cancelled share premium account not yet distributable

(44,315)

-

(44,315)

Reserves available for distribution*

7,879

-

7,879

* subject to filing these interim financial statements at Companies House.

The capital reserve and the revenue reserve are both distributable reserves. These reserves total £53,297,000, representing an increase of £39,476,000 in the period since 31 December 2021. The directors also consider the level of the investment holding gains and losses reserve and the future requirements of the Company when determining the level of dividend payments.

Of the potentially distributable reserves of £53,297,000 shown above, £1,103,000 relates to income not yet distributable and £44,315,000 to cancelled share premium which becomes distributable from 2022 onwards (see below).

Total share premium previously cancelled is available for distribution from the following dates.

£000

Once these interim accounts have been filed at Companies House

4,351

1 January 2023

12,085

1 January 2024

299

1 January 2025

7,387

1 January 2026

20,193

Cancelled share premium account not yet distributable

 

 

44,315

 

UNAUDITED STATEMENT OF CASH FLOWS

for the six months ended 30 June 2022

Notes

Unaudited

6 months

ended

30 June

2022

Unaudited

6 months 

ended

30 June

2021

Audited

year

ended

31 December

2021

 

£000

£000

£000

Profit before taxation

 

1,163

14,005

20,389

Increase in provisions for liabilities and charges

7

363

3,316

-

(Decrease) increase in trade and other payables

 

(4,427)

(49)

4,412

Increase in accrued income and other assets

 

(30)

(87)

(117)

Gains on disposal of investments

 

-

(105)

(5,342)

Gains on investments held at fair value

 

(2,364)

(17,741)

(20,702)

Capitalised income

 

-

-

(59)

Net cash outflow from operating activities

 

(5,295)

(661)

(1,419)

Cash flows (used in) from investing activities

 

 

 

Purchase of financial assets at fair value through profit or loss

6

(6,425)

(4,306)

(6,092)

Proceeds from sale of financial assets at fair value through profit or loss

6

-

-

11,182

Deferred consideration

6

4

471

471

Net cash (outflow) inflow from investing activities

 

(6,421)

(3,835)

5,561

Cash flows from (used in) financing activities

 

 

 

Issue of ordinary shares

 

25,297

7,048

7,050

Costs of ordinary share issues*

 

(1,103)

(244)

(286)

Purchase of own shares

 

(920)

(1,161)

(1,942)

Dividends paid

4

(2,176)

(1,536)

(8,765)

Net cash inflow (outflow) from financing activities

 

21,098

4,107

(3,943)

 

 

Net increase (decrease) in cash and cash equivalents

 

9,382

(389)

199

Cash and cash equivalents at the beginning of the period

 

19,201

19,002

19,002

Cash and cash equivalents at the end of the period

 

28,583

18,613

19,201

 

*Issue costs include both fundraising costs and expenses incurred from the Company's DRIS.

 

EXPLANATORY NOTES TO THE UNAUDITED CONDENSED FINANCIAL STATEMENTS

1 General Information, Basis of Preparation and Principal Accounting Policies

These half year statements have been approved by the directors whose names appear at note 10, each of whom has confirmed that to the best of their knowledge:

• the interim management report includes a fair review of the information required by rules 4.2.7 and 4.2.8 of the Disclosure Rules and the Transparency Rules; and

• the half year statements have been prepared in accordance with IAS 34 'Interim financial reporting' and the Disclosure and Transparency Rules of the Financial Conduct Authority.

The half year statements are unaudited and have not been reviewed by the auditors pursuant to the International Standard on Review Engagements (UK and Ireland) 2410 guidance on Review of Interim Financial Information performed by the independent Auditor of the entity. They do not constitute full financial statements as defined in section 435 of the Companies Act 2006. The comparative figures for the year ended 31 December 2021 do not constitute full financial statements and have been extracted from the Company's financial statements for the year ended 31 December 2021. Those accounts were reported upon without qualification by the auditors and have been delivered to the Registrar of Companies.

The accounting policies and methods of computation followed in the half year statements are the same as those adopted in the preparation of the audited financial statements for the year ended 31 December 2021. They do not include all disclosures that would otherwise be required in a complete set of financial statements and should be read in conjunction with the 2021 annual report.

The accounts have been prepared on a going concern basis as set out below and in accordance with UK adopted international accounting standards.

The accounts have been prepared under the historical cost basis as modified by the measurement of investments at fair value through profit or loss.

The accounts have been prepared in compliance with the recommendations set out in the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' issued by the Association of Investment Companies (issued in April 2021 - "SORP") to the extent that they do not conflict with UK adopted international accounting standards.

The financial statements are prepared in accordance with UK adopted international accounting standards (IFRSs) and interpretations in force at the reporting date. New standards coming into force during the period and future standards that come into effect after the period-end have not had a material impact on these financial statements.

The Company has carried out an assessment of accounting standards, amendments and interpretations that have been issued by the IASB and that are effective for the current reporting period. The Company has determined that the transitional effects of the standards do not have a material impact.

The financial statements are presented in sterling and all values are rounded to the nearest thousand (£000), except where stated.

 

Going Concern: The directors have carefully considered the issue of going concern and are satisfied that the Company has sufficient resources to meet its obligations as they fall due for a period of at least twelve months from the date these half year statements were approved. As at 30 June 2022 the Company held cash balances and fixed term deposits with a combined value of £30,571,000. Cash flow projections show the Company has sufficient funds to meet both its contracted expenditure and its discretionary cash outflows in the form of share buy-backs and the dividend policy. In the year ended 31 December 2021 the Company's costs and discretionary expenditures were:

£'000

Administrative expenses (before incentive fee)

1,909

Share buybacks

1,942

Dividends (before DRIS)

11,015

Total

14,866

 

The directors therefore believe that it is appropriate to continue to apply the going concern basis of accounting in preparing these half year statements.

2 Income

Unaudited

6 months

ended

30 June

2022

£000

Unaudited

6 months

ended

30 June

2021

£000

Income from investments

 

- Dividends from unquoted companies

114

155

- Interest on loans to unquoted companies

100

152

Income from investments held at fair value through profit or loss

214

307

Interest on bank deposits

61

30

275

337

 

3 Taxation

Unaudited 6 months ended

30 June 2022

Unaudited 6 months ended

30 June 2021

Revenue

Capital

Total

Revenue

Capital

Total

£000

£000

£000

£000

£000

£000

(Loss) profit before taxation

(225)

1,388

1,163

(34)

14,039

14,005

(Loss) profit before taxation multiplied by the standard small company rate of corporation tax in UK of 19.0% (2021: 19.0%)

(43)

264

221

(6)

2,667

2,661

Effect of:

 

 

 

UK dividends received

(22)

-

(22)

(30)

-

(30)

Non-taxable profits on investments

-

(449)

(449)

-

(3,391)

(3,391)

Deferred tax not recognised

65

185

250

36

724

760

Tax charge

-

-

-

-

-

-

 

The Company has no provided, or unprovided, deferred tax liability in either period. Deferred tax assets in respect of losses have not been recognised as the directors do not currently believe that it is probable that sufficient taxable profits will be available against which the assets can be recovered.

Due to the Company's status as a venture capital trust, and the continued intention to meet the conditions required to comply with Chapter 3 Part 6 of the Income Tax Act 2007, the Company has not provided deferred tax on any capital gains or losses arising on the revaluation or realisation of investments.

4 Dividends

Amounts recognised as distributions to equity holders in the period:

Unaudited

6 months ended

30 June 2022

Unaudited

6 months ended

30 June 2021

Audited

Year ended

31 December 2021

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

£000

£000

£000

£000

£000

£000

£000

£000

£000

Interim dividend for the year ending 31 December 2022 of 1.5p (2021: 1.5p) per ordinary share

-

2,718

2,718

-

1,934

1,934

-

1,934

1,934

 

 

 

Second interim dividend for the year ended 31 December 2021 of 1.5p per ordinary share

-

-

-

-

-

1,559

544

2,103

 

 

 

Third interim dividend for the year ended 31 December 2021 of 5.0p per ordinary share

 

 

 

-

-

-

6,978

6,978

-

-

-

-

2,718

2,718

-

1,934

1,934

1,559

9,456

11,015

Shares allotted under DRIS

 

 

(542)

(398)

(2,250)

Dividends paid in the Statement of Cash Flows

 

 

2,176

1,536

8,765

 

The interim dividend of 1.5 pence per ordinary share was paid on 6 May 2022 to shareholders on the register as at 1 April 2022.

An interim dividend of 1.5 pence per ordinary share, amounting to approximately £2.7 million, is proposed. The dividend has not been recognised in these half year financial statements as the obligation did not exist at the balance sheet date.

5 Basic and Diluted (Loss) / Earnings per Ordinary Share

The basic and diluted earnings per ordinary share is based on the profit after tax attributable to equity shareholders of £1,163,000 (30 June 2021: £14,005,000) and 180,486,872 (30 June 2021: 136,437,520) ordinary shares being the weighted average number of ordinary shares in issue during the period.

The basic and diluted revenue loss per ordinary share is based on the revenue loss attributable to equity shareholders of £225,000 (30 June 2021: £34,000) and 180,486,872 (30 June 2021: 136,437,520) ordinary shares being the weighted average number of ordinary shares in issue during the period.

The basic and diluted capital earnings per ordinary share is based on the capital profit attributable to equity shareholders of £1,388,000 (30 June 2021: £14,039,000) and 180,486,872 (30 June 2021: 136,437,520) ordinary shares being the weighted average number of ordinary shares in issue during the period.

During the period the Company allotted 40,224,521 new ordinary shares from the fundraising, and 903,714 new ordinary shares in respect of its DRIS.

The Company has also repurchased 1,562,710 of its own shares in the period and these shares are held in the capital reserve. The total of 17,492,484 treasury shares has been excluded in calculating the weighted average number of ordinary shares during the period.

The Company has no dilutive shares and consequently, basic and diluted earnings per ordinary share are equivalent at 30 June 2022, 31 December 2021 and 30 June 2021.

6 Financial Assets at Fair Value through Profit or Loss

IFRS 13 and IFRS 7, in respect of financial instruments that are measured in the balance sheet at fair value, require disclosure of fair value measurements by level within the following fair value measurement hierarchy:

Level 1: quoted prices in active markets for identical assets or liabilities. The fair value of financial instruments traded in active markets is based on quoted market prices at the balance sheet date. A market is defined as a market in which transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis. The quoted market price used for financial assets held by the Company is the current bid price. These instruments are included in level 1 and comprise listed investment funds classified as held at fair value through profit or loss.

Level 2: the fair value of financial instruments that are not traded in an active market is determined by using valuation techniques. These valuation techniques maximise the use of observable market data where it is available and rely as little as possible on entity specific estimates. If all significant inputs required to fair value an instrument are observable, the instrument is included in Level 2. The Company held no such instruments in the current or prior year.

Level 3: the fair value of financial instruments that are not traded in an active market (for example, investments in unquoted companies) is determined by using valuation techniques such as revenue or earnings multiples. If one or more of the significant inputs is not based on observable market data, the instrument is included in Level 3. The majority of the Company's investments fall into this category.

Each investment is reviewed at least quarterly to ensure that it has not ceased to meet the criteria of the level in which it was included at the beginning of each accounting period. There have been no transfers between these classifications in the period (2021: none).

The change in fair value for the current and previous year is recognised through profit or loss. All items held at fair value through profit or loss were designated as such upon initial recognition.

Valuation of Investments

Unquoted investments are valued in accordance with IFRS 13 "Fair Value Measurement" and using the International Private Equity and Venture Capital ("IPEVC") Valuation Guidelines ("the Guidelines") issued in December 2018.

Initial measurement

The best estimate of the initial fair value of an unquoted investment is the cost of the investment. Unless there are indications that this is inappropriate, an unquoted investment will be held at this value within the first three months of investment.

Subsequent measurement

Based on the Guidelines we have identified six of the most widely used valuation methodologies for unquoted investments. The Guidelines advocate that the best valuation methodologies are those that draw on external, objective market-based data in order to derive a fair value.

Full details of the methods used by the Company were set out on pages 66 and 67 of the financial statements for the year ended 31 December 2021, a copy of which can be found at www.bscfunds.com.

The primary methods used for valuing non-quoted investments, and the key assumptions relating to them are:

Unquoted Investments

> revenue multiple. An appropriate multiple, given the risk profile and sales growth prospects of the underlying company, is applied to the revenue of the company. The multiple is adjusted to reflect any risk associated with lack of marketability and to take account of the differences between the investee company and the benchmark company or companies used to derive the multiple.

> earnings multiple. An appropriate multiple, given the risk profile and earnings growth prospects of the underlying company, is applied to the maintainable earnings of the company. The multiple is adjusted to reflect any risk associated with lack of marketability and to take account of the differences between the investee company and the benchmark company or companies used to derive the multiple.

Level 3 Unquoted Investments

Level 1 Listed Investment Funds

Total Investments

IFRS 13 measurement classification

£000

£000

£000

Opening cost

42,037

-

42,037

Opening valuation gain

27,982

-

27,982

Opening fair value at 1 January 2022

70,019

-

70,019

Additions at cost

5,747

678

6,425

Change in fair value

2,395

(31)

2,364

Closing fair value at 30 June 2022

78,161

647

78,808

Closing cost

47,784

678

48,462

Closing valuation gain (loss)

30,377

(31)

30,346

Closing fair value at 30 June 2022

78,161

647

78,808

Movements in investments at fair value through profit or loss during the six months to 30 June 2022 are summarised as follows:

Level 3 valuations include assumptions based on non-observable data, such as discounts applied either to reflect changes in the fair value of financial assets held at the price of recent investment, or to adjust revenue or earnings multiples.

IFRS13 requires disclosure, by class of financial instruments, if the effect of changing one or more inputs to reasonably possible alternative assumptions would result in a significant change to fair value measurement. Each unquoted portfolio company has been reviewed and both downside and upside alternative assumptions have been identified and applied to the valuation of each of the unquoted investments. Applying the downside alternative the value of the unquoted investments would be £3,943,000 (5.0 per cent) lower. Using the upside alternative the value would be increased by £3,826,000 (4.9 per cent).

99 per cent of the Company's investments are in unquoted companies held at fair value. The valuation methodology for these investments includes the application of externally produced revenue and earnings multiples. Therefore the value of the unquoted element of the portfolio is also indirectly affected by price movements on the listed market. Those using revenue and earnings multiple methodologies include judgements regarding the level of discount applied to that multiple. The effect of changing the level of discounts applied to the multiples is considered above.

1 per cent of the Company's investments are investment funds listed on the main market of the London Stock Exchange (including FCA authorised and regulated UCITS funds). A 5 per cent increase in stock prices as at 30 June 2022 would have increased the net assets attributable to the Company's shareholders and the total profit by £32,000. An equal change in the opposite direction would have decreased the net assets attributable to the Company's shareholders and the total profit by an equal amount.

There have been no individual fair value adjustments downwards during the period that exceeded 5 per cent of the total assets of the Company (31 December 2021: none).

There were no realisations during the period. £4,000 was received during the period relating to investments realised prior to 31 December 2021.

7 Provisions for Liabilities and Charges

Incentive Fee

Under the terms of the Subscription Rights Agreement, the Manager and Chord Capital are entitled to a performance-related incentive fee if the cumulative dividends per ordinary share paid as at the last business day of December in any year, plus the average of the middle market price per ordinary share of the five dealing days prior to that day, exceeds a Hurdle. The Hurdle for the year ending 31 December 2022 is 135.5 pence per ordinary share. The value of the incentive fee is 20 per cent of the excess to the Hurdle, multiplied by the number of ordinary shares issued. At 30 June 2022 the total of cumulative cash dividends paid and the mid-market price was 136.5 pence per ordinary share. In accordance with the Company's accounting policy, an accrual of £363,000 has been recognised based on the number of shares in issue at 30 June 2022.

8 Basic and Diluted Net Asset Value per Ordinary Share

The basic and diluted net asset value per ordinary share is calculated on attributable assets of £109,636,000 (30 June 2021 and 31 December 2021: £89,041,000 and £87,375,000 respectively) and 181,720,724 (30 June 2021 and 31 December 2021: 140,231,049 and 142,155,199 respectively) ordinary shares in issue at 30 June 2022.

The 17,492,484 (30 June 2021 and 31 December 2021: 14,601,235 and 15,929,774 respectively) treasury shares have been excluded in calculating the number of ordinary shares in issue at 30 June 2022.

The Company has no potentially dilutive shares and consequently, basic and diluted net asset values are equivalent at 30 June 2022, 31 December 2021 and 30 June 2021.

9 Total Return

Total Return per ordinary share is calculated on cumulative dividends paid of 79.5 pence per ordinary share (30 June 2021: 71.5 pence per ordinary share and 31 December 2021: 78.0 pence per ordinary share) plus the net asset value as calculated in note 8.

10 Directors

The directors of the Company are: Peter C Waller, Barbara L Anderson, and Roger S McDowell.

11 Other Information

Copies of the interim report can be obtained from the Company's registered office: 5th Floor, Valiant Building, 14 South Parade, Leeds, LS1 5QS or from www.bscfunds.com.

12 Interim Dividend for the year ending 31 December 2022

The directors have previously announced the payment of a second interim dividend for the year ending 31 December 2022 of 1.5 pence per ordinary share ("Interim Dividend").

The Interim Dividend will be paid on 3 October 2022 to those shareholders on the Company's register at the close of business on 2 September 2022. The ex-dividend date will be 1 September 2022.

 

13 Dividend Re-investment Scheme

The Company operates a DRIS. The latest date for receipt of DRIS elections so as to participate in the DRIS in respect of the Interim Dividend is the close of business on 16 September 2022.

 

14 Inside Information

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

For further information, please contact:

 

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR DBLBLLKLXBBB
Date   Source Headline
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20247:57 amRNSIssue of Equity and Close of Offers
26th Mar 202411:10 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20247:40 amRNSAppointment of non-executive Director
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNSAnnual Financial Report
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:26 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSIssue of Equity
18th Dec 20234:04 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
24th Nov 20237:00 amRNS3rd Quarter Results
3rd Nov 20239:40 amRNSPayment of dividend and issue of equity
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:16 amRNSTransaction in Own Shares
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
13th Sep 20237:00 amRNSHalf-year Report
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
27th Jun 20237:46 amRNSTransaction in Own Shares
26th Jun 202310:57 amRNSDirector/PDMR Shareholding
26th Jun 202310:56 amRNSPayment of Dividend and Issue of Equity
16th Jun 202312:00 pmRNS1st Quarter Results
15th Jun 20233:17 pmRNSResult of Meeting
15th Jun 20233:16 pmRNSResult of AGM
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:22 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:40 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
23rd Mar 202311:30 amRNSPublication of Circular
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNSAnnual Financial Report
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:50 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.